Edition:
United Kingdom

Enzo Biochem Inc (ENZ.N)

ENZ.N on New York Stock Exchange

7.79USD
18 Jan 2018
Change (% chg)

$0.04 (+0.52%)
Prev Close
$7.75
Open
$7.69
Day's High
$7.82
Day's Low
$7.69
Volume
31,140
Avg. Vol
56,782
52-wk High
$12.04
52-wk Low
$6.27

Chart for

About

Enzo Biochem, Inc. is a bioscience company focusing on delivering and applying technology capabilities to produce products and services. The Company's segments include Enzo Clinical Labs, Enzo Life Sciences and Enzo Therapeutics. Enzo Clinical Labs is a clinical reference laboratory providing a range of clinical services to... (more)

Overall

Beta: 0.85
Market Cap(Mil.): $485.96
Shares Outstanding(Mil.): 46.55
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 28.44 16.58
EPS (TTM): -- -- --
ROI: -- 6.45 10.60
ROE: -- 10.10 14.19

BRIEF-Enzo Biochem Q1 Non-GAAP Loss Per Share $0.01

* Q1 REVENUE $27.7 MILLION VERSUS $26.3 MILLION Source text for Eikon: Further company coverage:

07 Dec 2017

BRIEF-‍Enzo Biochem announces NYS department of health's approval of a new women's health infectious disease panel​

* ‍Enzo Biochem announces NYS department of health's approval of a new women's health infectious disease panel​ Source text for Eikon: Further company coverage:

23 Oct 2017

CORRECTED-BRIEF-Enzo Biochem Q4 non-gaap net income of $0.00 per share (Sept 27)

(Corrects headline and third bullet to Q4 non-gaap net income of $0.00/share from non-gaap loss of $0.04/share) Enzo Biochem Inc:

28 Sep 2017

BRIEF-Enzo Biochem files for mixed shelf of up to $150 million ‍​

* Files for mixed shelf of up to $150 million - SEC filing ‍​ Source text for Eikon: Further company coverage:

01 Sep 2017

BRIEF-Enzo Biochem says federal judge in a U.S. Court has entered an order in action entitled Enzo Life Sciences v. Abbott Laboratories ​

* Enzo Biochem says ‍a federal judge in a U.S. Court has entered an order in action entitled Enzo Life Sciences, Inc. v. Abbott Laboratories - sec filing​

16 Aug 2017

Earnings vs. Estimates